Celldex Therapeutics Inc (FRA:TCE2)
€ 19.6 +0.10 (+0.51%) Market Cap: 1.28 Bil Enterprise Value: 704.31 Mil PE Ratio: 0 PB Ratio: 2.12 GF Score: 59/100

Celldex Therapeutics Inc (FRA:TCE2) Transcripts

  • 1